CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+16.96%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(+32%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
20%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
34
New
5
Increased
14
Reduced
3
Closed
5
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$26.1M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$16.3M |
| 3 |
Merus
MRUS
|
$15.8M |
| 4 |
Tenaya Therapeutics
TNYA
|
$10.6M |
| 5 |
Aclaris Therapeutics
ACRS
|
$9.38M |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$14.9M |
| 2 |
Astria Therapeutics
ATXS
|
$12.2M |
| 3 |
MacroGenics
MGNX
|
$10.6M |
| 4 |
ESSA Pharma
EPIX
|
$8.05M |
| 5 |
Mersana Therapeutics
MRSN
|
$5.83M |
Sector Composition
| 1 | Healthcare | 92.47% |
| 2 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $44.7M | 11.78% |
2,750,137
+1,001,896
| +57% | +$16.3M |
|
|
2
Aclaris Therapeutics
ACRS
$209M
| $39.4M | 10.39% |
2,190,291
+521,304
| +31% | +$9.38M |
|
3
Cytokinetics
CYTK
$4.23B
| $28.5M | 7.51% |
796,578
+92,261
| +13% | +$3.3M |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $26.1M | 6.87% |
+1,292,251
| New | +$26.1M |
|
5
C4 Therapeutics
CCCC
$185M
| $21.5M | 5.67% |
481,094
| – | – |
|
6
Kura Oncology
KURA
$686M
| $18.7M | 4.94% |
999,433
+377,940
| +61% | +$7.08M |
|
7
Celcuity
CELC
$2.17B
| $16.6M | 4.37% |
920,464
+49,497
| +6% | +$891K |
|
8
Cogent Biosciences
COGT
$1.69B
| $16.1M | 4.24% |
1,912,511
+544,929
| +40% | +$4.58M |
|
|
9
Merus
MRUS
$4.98B
| $15.8M | 4.17% |
+718,136
| New | +$15.8M |
|
|
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
| $15.2M | 4.01% |
4,169,896
+640,431
| +18% | +$2.34M |
|
|
STSA
11
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $14.5M | 3.83% |
3,118,761
+22,032
| +0.7% | +$103K |
|
12
VistaGen Therapeutics
VTGN
$102M
| $14M | 3.7% |
5,123,509
+1,792,194
| +54% | +$4.91M |
|
13
Celldex Therapeutics
CLDX
$1.47B
| $13.4M | 3.53% |
248,207
-75,230
| -23% | -$4.06M |
|
14
Viridian Therapeutics
VRDN
$1.5B
| $11M | 2.9% |
667,674
+481,269
| +258% | +$7.92M |
|
|
15
Tenaya Therapeutics
TNYA
$184M
| $10.6M | 2.8% |
+513,930
| New | +$10.6M |
|
16
Iovance Biotherapeutics
IOVA
$807M
| $8.95M | 2.36% |
+362,869
| New | +$8.95M |
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $8.85M | 2.33% |
579,432
+253,096
| +78% | +$3.87M |
|
18
Protagonist Therapeutics
PTGX
$3.67B
| $8.83M | 2.33% |
498,079
+287,479
| +137% | +$5.09M |
|
|
KRON
19
DELISTED
Kronos Bio
KRON
| $6.26M | 1.65% |
298,839
| – | – |
|
20
Revolution Medicines
RVMD
$7.1B
| $6.22M | 1.64% |
+226,228
| New | +$6.22M |
|
|
GNCA
21
DELISTED
Genocea Biosciences, Inc.
GNCA
| $5.91M | 1.56% |
3,079,756
+150,309
| +5% | +$289K |
|
22
KalVista Pharmaceuticals
KALV
$678M
| $5.45M | 1.44% |
312,553
+85,882
| +38% | +$1.5M |
|
23
Dyne Therapeutics
DYN
$1.92B
| $4.96M | 1.31% |
305,125
| – | – |
|
|
MREO
24
Mereo BioPharma
MREO
$272M
| $4.78M | 1.26% |
1,972,958
-86,771
| -4% | -$210K |
|
25
PMV Pharmaceuticals
PMVP
$74.2M
| $3.73M | 0.98% |
125,000
| – | – |
|